COVID
345
11
15
176
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
32 trials with published results (9%)
Research Maturity
176 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.1%
35 terminated out of 345 trials
83.4%
-3.2% vs benchmark
10%
33 trials in Phase 3/4
18%
32 of 176 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 176 completed trials
Clinical Trials (345)
A Study to Explore the Role of Gut Flora in COVID-19 Infection
COVID-19 in PID Survey
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
Long-term Impact of Infection With Novel Coronavirus (COVID-19)
The Effects of Endotracheal Suctioning on Pain and Serum Markers
Assessment of Chilbains Occuring During Covid-19 Infection
Cohort Study of Intraoperative Lung Protective Ventilation Trends in a Large Canadian Health Authority
One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)
COVID-19 Biorepository
Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment
Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19
Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome
Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic
Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19)
Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection
Vitamin D Levels in SARS-CoV-2: Do Current Adequacy Thresholds Reflect Clinical Risk? Insights From a Large Turkish Cohort
Risk of Air Contamination During Visceral Surgery in COVID19 Patients
Intermediate IND Severe Illness COVID-19 CP